Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jin-shui Huan-xian granule in IPF
NCT04187690Unknown
- Sponsor
- Henan University of Chinese Medicine
- Start
- Sep 2020
- Primary completion
- May 2023
- Modality
- HM (Herbal Medicine)
- Countries
- 1
01
Overview
Randomised, double-blind trial in idiopathic pulmonary fibrosis (IPF) comparing Jin-shui Huan-xian granule with Placebo (2 arms). Primary endpoints: Frequencies of acute exacerbations at 52 weeks, Six-minute walking distance at 52 weeks and 1 more. Status: unknown.
02
Drugs
Jinshui Huanxian
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT04187690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04187690.